Physiology-guided myocardial revascularisation in complex multivessel coronary artery disease: beyond the 2014

Jan J Piek1, Bimmer E Claessen1, Justin E Davies2

  • 1AMC Heart Center, Academic Medical Center, University of Amsterdam , Amsterdam , The Netherlands.

Open Heart
|October 30, 2015
PubMed

Insights

Percutaneous coronary intervention (PCI) guided by physiology is a viable alternative to bypass surgery for complex multivessel disease. Current guidelines overlook this approach for stable angina patients with significant coronary artery disease.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiothoracic Surgery

Background:

  • Revascularization for multivessel coronary artery disease (MVD) involves Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG).
  • Clinical decisions are made by a heart team, considering European guidelines for myocardial revascularization.
  • Current guidelines recommend CABG over PCI for stable angina with three-vessel disease and high SYNTAX scores (≥23).

Purpose of the Study:

  • To argue for the inclusion of physiology-guided PCI in treatment recommendations for MVD.
  • To highlight the potential of current-generation drug-eluting stents in physiology-guided PCI for complex MVD.

Main Methods:

  • This is a viewpoint article, not a clinical trial.
  • It analyzes current European guidelines on myocardial revascularization.
  • It discusses the role of functional assessment in guiding PCI for MVD.

Main Results:

  • Current guidelines do not provide recommendations for physiology-guided PCI in MVD.
  • The authors advocate for considering physiology-guided PCI as a reasonable alternative.

Conclusions:

  • Physiology-guided PCI using modern drug-eluting stents is a potential alternative for complex multivessel disease.
  • The omission of physiology-guided PCI recommendations in current guidelines is considered an oversight.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
400
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
450
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
637